Copyright Reports & Markets. All rights reserved.

Global Influenza Vaccines Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    Global Influenza Vaccines Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Influenza Vaccines Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Influenza Vaccines Market Size Growth Rate by Type
        • 1.4.2 Paediatrics
        • 1.4.3 Adolescence
        • 1.4.4 Adults
        • 1.4.5 Elderly
      • 1.5 Market by Application
        • 1.5.1 Global Influenza Vaccines Market Size Growth Rate by Application
        • 1.5.2 Hospitals
        • 1.5.3 Clinics
        • 1.5.4 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Influenza Vaccines Production
        • 2.1.1 Global Influenza Vaccines Revenue 2014-2025
        • 2.1.2 Global Influenza Vaccines Production 2014-2025
        • 2.1.3 Global Influenza Vaccines Capacity 2014-2025
        • 2.1.4 Global Influenza Vaccines Marketing Pricing and Trends
      • 2.2 Influenza Vaccines Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Influenza Vaccines Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Influenza Vaccines Production by Manufacturers
        • 3.1.1 Influenza Vaccines Production by Manufacturers
        • 3.1.2 Influenza Vaccines Production Market Share by Manufacturers
      • 3.2 Influenza Vaccines Revenue by Manufacturers
        • 3.2.1 Influenza Vaccines Revenue by Manufacturers (2014-2019)
        • 3.2.2 Influenza Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.3 Influenza Vaccines Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Influenza Vaccines Production by Regions

      • 4.1 Global Influenza Vaccines Production by Regions
        • 4.1.1 Global Influenza Vaccines Production Market Share by Regions
        • 4.1.2 Global Influenza Vaccines Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Influenza Vaccines Production
        • 4.2.2 United States Influenza Vaccines Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Influenza Vaccines Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Influenza Vaccines Production
        • 4.3.2 Europe Influenza Vaccines Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Influenza Vaccines Import & Export
      • 4.4 China
        • 4.4.1 China Influenza Vaccines Production
        • 4.4.2 China Influenza Vaccines Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Influenza Vaccines Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Influenza Vaccines Production
        • 4.5.2 Japan Influenza Vaccines Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Influenza Vaccines Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Influenza Vaccines Consumption by Regions

      • 5.1 Global Influenza Vaccines Consumption by Regions
        • 5.1.1 Global Influenza Vaccines Consumption by Regions
        • 5.1.2 Global Influenza Vaccines Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Influenza Vaccines Consumption by Application
        • 5.2.2 North America Influenza Vaccines Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Influenza Vaccines Consumption by Application
        • 5.3.2 Europe Influenza Vaccines Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Influenza Vaccines Consumption by Application
        • 5.4.2 Asia Pacific Influenza Vaccines Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Influenza Vaccines Consumption by Application
        • 5.5.2 Central & South America Influenza Vaccines Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Influenza Vaccines Consumption by Application
        • 5.6.2 Middle East and Africa Influenza Vaccines Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Influenza Vaccines Breakdown Dada by Type
      • 6.2 Global Influenza Vaccines Revenue by Type
      • 6.3 Influenza Vaccines Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Influenza Vaccines Breakdown Dada by Application
        • 7.2.1 Global Influenza Vaccines Consumption by Application
        • 7.2.2 Global Influenza Vaccines Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 GSK
        • 8.1.1 GSK Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Influenza Vaccines
        • 8.1.4 Influenza Vaccines Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Novartis
        • 8.2.1 Novartis Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Influenza Vaccines
        • 8.2.4 Influenza Vaccines Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 CSL
        • 8.3.1 CSL Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Influenza Vaccines
        • 8.3.4 Influenza Vaccines Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 MedImmune
        • 8.4.1 MedImmune Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Influenza Vaccines
        • 8.4.4 Influenza Vaccines Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Sanofi-Pasteur
        • 8.5.1 Sanofi-Pasteur Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Influenza Vaccines
        • 8.5.4 Influenza Vaccines Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Solvay
        • 8.6.1 Solvay Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Influenza Vaccines
        • 8.6.4 Influenza Vaccines Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Sinovac Biotech
        • 8.7.1 Sinovac Biotech Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Influenza Vaccines
        • 8.7.4 Influenza Vaccines Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Hualun Biologicals
        • 8.8.1 Hualun Biologicals Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Influenza Vaccines
        • 8.8.4 Influenza Vaccines Product Description
        • 8.8.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Influenza Vaccines Production and Revenue Forecast
        • 9.1.1 Global Influenza Vaccines Production Forecast 2019-2025
        • 9.1.2 Global Influenza Vaccines Revenue Forecast 2019-2025
      • 9.2 Influenza Vaccines Production and Revenue Forecast by Regions
        • 9.2.1 Global Influenza Vaccines Revenue Forecast by Regions
        • 9.2.2 Global Influenza Vaccines Production Forecast by Regions
      • 9.3 Influenza Vaccines Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Influenza Vaccines Production Forecast by Type
        • 9.4.2 Global Influenza Vaccines Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Influenza Vaccines Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Influenza Vaccines Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Influenza Vaccines Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Influenza Vaccines Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Influenza Vaccines Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Influenza Vaccines Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Influenza Vaccines Upstream Market
        • 11.1.1 Influenza Vaccines Key Raw Material
        • 11.1.2 Typical Suppliers of Key Influenza Vaccines Raw Material
        • 11.1.3 Influenza Vaccines Raw Material Market Concentration Rate
      • 11.2 Influenza Vaccines Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Influenza Vaccines Distributors
      • 11.5 Influenza Vaccines Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Influenza vaccine typically known as flu shot and is used for protection against influenza virus. 
        Global Influenza Vaccines market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Influenza Vaccines.

        This report researches the worldwide Influenza Vaccines market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
        This study categorizes the global Influenza Vaccines breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        GSK
        Novartis
        CSL
        MedImmune
        Sanofi-Pasteur
        Solvay
        Sinovac Biotech
        Hualun Biologicals

        Influenza Vaccines Breakdown Data by Type
        Paediatrics
        Adolescence
        Adults
        Elderly
        Influenza Vaccines Breakdown Data by Application
        Hospitals
        Clinics
        Others

        Influenza Vaccines Production Breakdown Data by Region
        United States
        Europe
        China
        Japan
        Other Regions

        Influenza Vaccines Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Rest of South America
        Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

        The study objectives are:
        To analyze and research the global Influenza Vaccines capacity, production, value, consumption, status and forecast;
        To focus on the key Influenza Vaccines manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Influenza Vaccines :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Buy now